Drug Manufacturers - General

    Company InsiderPie Expert Score P/E ratio Gross margin EBIT margin ROA Net income per employee
    Amgen Inc. 52 / 100 22 66.1% 24.1% 7.8% €213.06K
    Gilead Sciences, Inc. 70 / 100 17 78.7% 36.1% 13.9% €392.43K
    Kyowa Kirin Co., Ltd. 51 / 100 34 72.6% 17.1% 3.6% €36.49K
    AbbVie Inc. 54 / 100 142 76.2% 21.8% 1.8% €37.07K
    Biogen Inc. 54 / 100 12 73.0% 25.4% 5.5% €180.13K
    Pfizer Inc. 58 / 100 17 73.4% 23.8% 4.7% €103.33K
    Merck & Co., Inc. 50 / 100 11 82.8% 39.4% 14.7% €222.06K
    Roche Holding AG 48 / 100 13 73.6% 29.1% 17.2% €170.62K
    Santen Pharmaceutical Co., Ltd. 51 / 100 19 55.5% 15.2% 7.7% €45.29K
    Sanofi 53 / 100 12 71.6% 26.6% 7.3% €110.11K
    Eli Lilly and Company 55 / 100 42 83.0% 43.9% 16.0% €333.63K
    Chugai Pharmaceutical Co., Ltd. 51 / 100 32 70.3% 47.1% 17.4% €423.71K
    Johnson & Johnson 53 / 100 17 67.9% 24.4% 11.7% €139.75K
    AstraZeneca PLC 54 / 100 0.33 80.3% 21.9% 8.3% €85.48K
    Dechra Pharmaceuticals PLC 50 / 100 1.5 56.4% 7.8% 1.9% €14.21K
    Recordati Industria Chimica e Farmaceutica S.p.A. 51 / 100 28 67.8% 25.5% 7.9% €88.92K
    Astellas Pharma Inc. 51 / 100 32 78.4% 5.2% 2.4% €29.77K
    GSK plc 51 / 100 0.11 72.3% 22.4% 9.0% €92.22K
    Virbac SA 50 / 100 9.7 66.6% 15.3% 15.1% €43.04K
    Bristol-Myers Squibb Company 51 / 100 17 51.0% 16.0% 6.2% €150.82K
    Grifols, S.A. 52 / 100 15 39.5% 18.2% 1.8% €15.21K
    Daiichi Sankyo Company, Limited 51 / 100 23 78.5% 17.3% 8.6% €85.08K
    Novartis AG 55 / 100 20 76.2% 31.1% 13.4% €161.53K

    Notifications